Replies to post #293 on Verastem (VSTM)

[MaineMan5]

I think it's a high-level, but accurate representation of what's going on. I do consider prices down here very attractive and will add on as I can.

Also, more good news just came out this afternoon comparing COPIKTRA to Novartis' ARZERRA:

https://seekingalpha.com/news/3395293-verastems-duvelisib-beats-novartis-arzerra-late-stage-blood-cancer-study-shares-1-percent